Central administration of 5‐HT activates 5‐HT1A receptors to cause sympathoexcitation and 5‐HT2/5‐HT1C receptors to release vasopressin in anaesthetized rats

British Journal of Pharmacology

Volumn 107, Issue 4, 1992, Pages 1020-1028

  Anderson, Ian K ^a   Martin, Graeme R ^a,b   Ramage, Andrew G ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

5 HT; 5 HT1A receptors; 5 HT2 or 5 HT1C receptors; 8 OH DPAT; anaesthetized rat; blood pressure; DOI; DP 5 CT; sympathetic nerve activity; vasopressin V1 receptors

Indexed keywords

1 ISOPROPYL 6 METHYLERGOLINE 8 CARBOXYLIC ACID 2 HYDROXY 1 METHYLPROPYL ESTER; 2 ANILINO N [2 (3 CHLOROPHENOXY)PROPYL]ACETAMIDINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 CARBAMOYL N,N DIPROPYLTRYPTAMINE; 5 CARBAMOYLTRYPTAMINE; CINANSERIN; METITEPINE; NITROPRUSSIDE SODIUM; NORADRENALIN; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1C RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SPIROXATRINE; VASOPRESSIN; VASOPRESSIN ANTAGONIST; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN[1 (3,3 CYCLOPENTAMETHYLENE 3 MERCAPTOPROPIONIC ACID) 2 (O METHYLTYROSINE) 8 DEXTRO ARGININE];

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HEART RATE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; KIDNEY NERVE; MALE; NERVE EXCITABILITY; NONHUMAN; PHRENIC NERVE; PRIORITY JOURNAL; RAT; SYMPATHETIC NERVE; VASOPRESSIN RELEASE;

ANIMAL; BLOOD PRESSURE; DIOXANES; HEART RATE; INJECTIONS, INTRAVENTRICULAR; KIDNEY; MALE; PHRENIC NERVE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, VASOPRESSIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SPIRO COMPOUNDS; SUPPORT, NON-U.S. GOV'T; SYMPATHETIC NERVOUS SYSTEM; TRYPTAMINES; VASOPRESSINS;

EID: 0026438756     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1992.tb13401.x     Document Type: Article

References (58)

1. 2 receptor agonist, in conscious rats
2. 1A receptors causes sympathoexcitation in anesthetized rats
3. Regional haemodynamic effects of 5‐HT i.c.v. in conscious Long‐Evans and Brattleboro rats
4. 2/1C receptors causes the release of vasopressin in anaesthetized rats
5. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists
6. Marked increases in plasma catecholamine concentrations preceded hypotension and bradycardia caused by 8‐hydroxy‐2‐(di‐n‐propylamino)‐tetralin (8‐OH‐DPAT) in conscious rats
7. Role of the adrenal gland in the metabolic and cardiovascular effects of 8‐OH‐DPAT
8. Neuropharmacological characterization of serotonergic stimulation of vasopression secretion in conscious rats
9. Sympathetic hyperactivity elevates blood pressure during acute cerebroventricular infusions of hypertonic salt in rats
10. 1A receptor agonists buspirone and ipsapirone activate adrenaline release in the conscious rat
11. 1A and alpha‐2 adrenergic receptors mediate the hyperglycaemic and hypoinsulinaemic effects of 8‐hydroxy‐2‐(di‐n‐propylamino)‐tetralin in conscious rats
12. Ganglionic transmission is a prerequisite for the adrenaline‐releasing and hyperglycaemic effects of 8‐OH‐DPAT
13. 2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat
14. 2 receptor antagonists
15. 1A receptor agonists injected into the dorsal raphe nucleus of conscious rats
16. The central antihypertensive action of 5‐hydroxytryptamine: the location of site of action
17. 2 receptors in the pithed rat
18. The cardiovascular effects of centrally administered 5‐hydroxytryptamine in the conscious normotensive and hypertensive rat
19. 1A receptor agonist: Cardiovascular excitation at low doses
20. 1A receptors and the mechanism of the central hypotensive effect of (+) 8‐OH‐DPAT, DP‐5‐CT, R28935, and urapidil
21. 1A receptor agonists into the raphe obscurus of the anaesthetized rat
22. Cardiovascular response to 8‐hydroxy‐2‐(di‐n‐propylamino) tetralin (8‐OH‐DPAT): Site of action and pharmacological analysis
23. Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW501C67
24. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function
25. The angiotensin II pressor system of the rat forebrain
26. Effect of electrical and chemical stimulation of the raphe obscurus on phrenic nerve activity in the cat
27. Involvement of serotonin in the excitation of phrenic motoneurones evoked by stimulation of the raphe obscurus
28. The 5‐HT receptor family: ligands, distribution and receptor‐effector coupling
29. Sympathetic inhibition and vasopressin mediation during centrally induced responses to serotonin in rats
30. Vasopressin release to central and peripheral angiotensin II in rats with lesions of the subfornical organ
31. Hypertension mediated by activation of the rat brain 5‐hydroxytryptamine receptor sites
32. Analysis of cardiovascular responses to central administration of 5‐hydroxytryptamine in rats
33. Centrally mediated cardiovascular responses to 5‐HT
34. Involvement of 5‐hydroxytryptamine in the central control of respiration, blood pressure and heart rate in the anaesthetized rat
35. Evaluation of the peripheral and central antagonistic activities against 5‐hydroxytryptamine of some new agents
36. 2 receptor agonists increase spontaneous sympathetic nerve discharge
37. 1 recognition site
38. 1A receptor ligand
39. 1A receptor antagonist
40. Role of the ventral lateral medulla in the sympatholytic effect of 8‐OH‐DPAT in rats
41. Vasopressin and autonomic mechanisms mediate cardiovascular actions of central serotonin
42. Effects of central serotonin on autonomic control of heart rate in intact and baroreceptor deficient rats
43. The effects of ketanserin, methysergide and LY 53857 on sympathetic nerve activity
44. 1A receptor agonists on sympathetic and parasympathetic nerve activity
45. 2 agonist, 1‐(2,5‐dimethoxy‐4‐idophenyl)‐2‐aminopropane (DOI), on cardiac sympathetic nerve activity in the anaesthetized cat
46. 2 adrenoceptor agonists in anaesthetised cats
47. A new potent and specific serotonin inhibitor (SQ 10,643) 2′‐(3‐dimethylaminopropylthio) cinnamanilide hydrochloride: antiserotonin activity on the uterus and on gastrointestinal, vascular and respiratory systems of animals
48. 1A binding sites inhibit forskolin‐stimulated adenylate cyclase activity in calf hippocampus
49. 2 agonist, 1‐(2,5‐dimethoxy‐4‐iodophenyl)‐2‐aminopropane (DOI), on autonomic outflow in the anaesthetized cat
50. Intrahypothalamic serotonin and cardiovascular control in the rat
51. 1A agonists into the dorsal motor vagal nucleus produce a bradycardia in the atenolol‐pretreated anaesthetised rat
52. Vasopressin release after enhanced serotonergic transmission is not due to activation of the renin‐angiotensin system
53. Cardiovascular responses to centrally administered serotonin in conscious normotensive and spontaneously hypertensive rats
54. Hypotensive effects of 8‐hydroxy‐2‐(di‐n‐propylamino)tetralin and 5‐methylurapidil following stereotaxic microinjection into the ventral medulla of the rat
55. Neuroendocrine pharmacology of serotonergic (5‐HT) neurons
56. 3 receptors in anaesthetised rats
57. 2 receptors: role of the ventrolateral pressor area